ABNX-100

N/A

Report date: 2025/06/11 11:11:39

Base Information

Drug NameABNX-100
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionApolipoprotein A-I modulators
TargetsApolipoprotein A-I
Therapy Area/IndicationsUveitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbionyx Pharma SA
China Registration ClassN/A

Develop Information

Active CompaniesAbionyx Pharma SA
Inactive CompaniesN/A
Active IndicationsUveitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A